Márcia Gaspar Nunes

TL;DR: The significant decreases in endometrial thickness and decreased uterine bleeding observed with doses of 30 and 40 mg/d as compared with placebo suggest endometrian antagonism, representing a novel characteristic not previously associated with any selective estrogen receptor modulator.

TL;DR: It was concluded that the daily standardized soy extract with 120 mg isoflavones' effect on symptoms was similar to that from estrogen, and Soy is oflavone has no effect on endometrium and vaginal mucosa during the treatment.

TL;DR: It is concluded that 100 mg/day isoflavone may be an alternative treatment for attenuating the climacteric symptoms in 80% of is oflavone users and that it reduced total cholesterol.

TL;DR: In this article, a randomized and double-blind study with 79 postmenopausal patients, 12 months of amenorrhea, 40 years old or more and body mass index (BMI) above 30 kg/m2.

TL;DR: There is no significant difference between women in menopausal transition and postmenopause, except in relation to the nutritional parameter, according to the Kupperman-Blatt Menopausal Index.